Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany, Austria and Switzerland - BALANCE

Trial Profile

Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany, Austria and Switzerland - BALANCE

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms BALANCE
  • Sponsors AbbVie
  • Most Recent Events

    • 09 Aug 2016 Planned number of patients changed from 266 to 250.
    • 13 Oct 2015 Planned number of patients changed from 250 to 266 as reported by ClinicalTrials.gov record.
    • 29 Apr 2015 Planned number of patients changed from 266 to 250 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top